A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ISIS 678354 Administered Subcutaneously to Patients with Severe Hypertriglyceridemia

Project: Research

Project Details

StatusActive
Effective start/end date25/08/22 → 24/08/27

Keywords

  • phase 3 study
  • randomised controlled trial (RCT)
  • Hypertriglyceridemia
  • treatment efficacy
  • treatment safety